That's quite interesting. I used to work in a lab that researched Wilson disease (the copper toxicity disorder the drug treats). Actually, increased copper levels in the brain have been linked to a myriad of other conditions, such as Alzheimers.
https://pubmed.ncbi.nlm.nih.gov/21770477/
Here they use TETA to treat diabetes related organ failure and suggest the drug may be useful against Alzheimers.
https://mct.aacrjournals.org/content/9/9/2458
This review summarizes TETA and mentions that it does get into the brain in rats.
Anyway, thinking as a big pharma might, one might suspect that they may not be as interested in investing too heavily in clinical trials for a drug that has been around since the mid 80s but I think that there is some promise in TETA.
KZA is well ahead of the game in many regards and it will be interesting to see the data that is coming, hopefully soon?
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-816
-
- There are more pages in this discussion • 1,251 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online